Status : Published | Published On : Dec, 2023 | Report Code : VRHC1071 | Industry : Healthcare | Available Format : | Page : 153 |
From USD 5.9 billion in 2023, the Global eClinical Solutions Market is predicted to grow to USD 16.4 billion by 2030, registering a CAGR of 14.0% during the forecast period (2025–2030). The market has witnessed huge demand for electronic data capture, and clinical data management system over the last few years, owing to the increasing demand for improved data standardization. Different types of solutions such as electronic data capture (EDC) and clinical data management system (CDMS), clinical trial management system (CTMS), clinical analytics platforms, and randomization and trial supply management are majorly contributing to the global eClinical solutions market size. The eClinical solutions market refers to the industry that provides technology-based solutions for clinical research and trials. These solutions are designed to streamline and optimize various aspects of the clinical trial process, including data management, patient recruitment, electronic data capture (EDC), clinical trial management systems (CTMS), randomization and trial supply management (RTSM), electronic patient reported outcomes (ePRO), and safety and pharmacovigilance.eClinical solutions aim to enhance efficiency, reduce costs, improve data quality, and accelerate the drug development process. By digitizing and automating manual processes, these solutions enable researchers and sponsors to collect, manage, and analyze clinical trial data more effectively. They also facilitate remote monitoring and real-time access to data, allowing for faster decision-making and improved collaboration among stakeholders involved in clinical trials.
eClinical solutions refer to software that helps researchers analyze new ways to manage and analyze clinical data. It is a combination of technology, products, and services, which is mainly engaged in data collection, integration, reporting, and localization of clinical trial data. Moreover, it reduces unnecessary data entry and decreases on-site verification and source data verification. Now these days rising clinical trials, R&D activities by pharmaceutical and biopharma organizations is the major factors driving the growth of the global eClinical solutions market.
Market Segmentation
Insight by Type
On the basis of type, the global eClinical solutions market is categorized into electronic data capture (EDC) and clinical data management system (CDMS), clinical trial management system (CTMS), clinical analytics platforms, randomization and trial supply management, clinical data integration platform, electronic clinical outcome assessment (eCOA) solutions, safety solutions, electronic trial master file system, and others.
The electronic data capture and clinical data management system category would hold the largest share in the eClinical solutions market, under the type segment, till 2027 However, during the forecast period, electronic clinical outcome assessment solutions category, on the basis of type, would witness fastest growth in the global eClinical systems market due to the growing need for electronic diaries in clinical studies, and the usage of mobile and digital technologies.
Insight by Delivery Mode
On the basis of the delivery mode, the global eClinical solutions market is segmented into on-demand/ web-based, on-premise, and cloud-based. during the forecast period, cloud-based category, would witness fastest growth in the global eClinical systems market. This would be a result of the reduced maintenance cost, ease of integration, quicker deployment, improved productivity, flexible scalability, and faster operation.
However, the on-demand/ web-based category would hold the largest share in the global eClinical solution systems market, under the delivery mode segment, till 2027. This would be a result of the decrease in price, quicker recovery of data, and easy user access.
Insight by End User
Based on end user, the global eClinical solutions market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting services companies, medical device manufacturers, hospitals, and academic research institute. Of all, the eClinical solutions market size for contract research organizations is expected to grow at the fastest rate during the forecast period, globally. In addition, of all end users, pharmaceutical and biopharmaceutical companies accounted for the largest share of the market in 2023.
Report Metric |
Details |
Historical Period |
2018 - 2023 |
Base Year Considered |
2024 |
Forecast Period |
2025 - 2030 |
Market Size in 2023 |
U.S.D. 5.9 Billion |
Revenue Forecast in 2030 |
U.S.D. 16.4 Billion |
Growth Rate |
14.0% |
Segments Covered in the Report |
By Type, Delivery Mode and By End User |
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
Regions Covered in the Report |
North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World |
Industry Dynamics
Growth Drivers
The key drivers driving the growth of the global eClinical solutions market are the increasing number of clinical trials, growing clinical trial outsourcing, rising implementation of software solution during clinical trials, budding demand for improved data standardization, expanding government grants to support clinical research, mounting demand for analyzing and tracking data and expanding research and development expenditure by pharma and biotech companies.
Owing to the growing geriatric population and mounting occurrence of chronic diseases has resulted in increased frequency of pipeline drugs, which further increases the number of clinical trials for the introduction of novel drugs. Other factors driving the growth of the global eClinical solutions market are the amplified IT budgets for drug development and modification from manual data analysis to real-time data analysis. Apart from this, increasing integration of software solutions in clinical trials is expected to provide a boost to the market. Currently due to increasing trend of outsourcing clinical trials to contract based labs/organization’s and is poised to aid the market gain in the coming times. Due to, growing number of research programs in European & Asian countries like China, India, Japan, Taiwan and development of cost-effective modules are anticipated for incremental demand for such solutions.
Challenges
Some of the major factors hampering the growth of the global eClinical solutions market are the high cost of implementation, the low adoption rate of the software, lack of high-speed broadband facility and long approval time. In addition, the dearth of skilled professionals is also having a negative impact on the growth of the market.
Geographic Overview
Around the globe, North America was the largest user of eClinical solutions in 2022, primarily due to a large number of industry players operating the North American market. Additionally, increasing demand for improved data standardization and increase in spends on research and development by pharmaceutical and biotechnology companies are also fueling the growth of the North American eClinical solutions market.
Asia-Pacific market is predicted to witness fastest growth in the global eClinical solutions market during the forecast period (2023–2030). The major factors driving the growth of the market in the APAC region are huge population base, easy patient recruitment, and the existence of less strict regulatory standards. Additionally, growing government sponsoring to strengthen clinical trials, the less operational cost for clinical trials, increasing healthcare expenditure, increasing outsourcing of clinical trials, and a growing number of pharmaceutical companies and CROs are also boosting the growth of the Asia-Pacific eClinical solutions industry. According to market reports, the eClinical solutions market is projected to continue growing in the coming years. Factors such as the increasing number of clinical trials, the adoption of cloud-based solutions, advancements in technology (such as artificial intelligence and machine learning), and the expanding scope of clinical research in emerging markets are expected to drive market growth. Additionally, the shift towards decentralized clinical trials and virtual trials, spurred by the pandemic, is likely to further fuel the demand for eClinical solutions.
Competitive Insight
Key market players in the global eClinical solutions industry are investing capital to develop technologically advanced systems. In February 2018, OmniComm Systems, Inc. acquired Algorics, to enhance its product portfolio in a clinical analytics solution.
The major players in the global eClinical solutions market are Oracle Corporation, PAREXEL International Corporation Medidata Solutions, Inc., DATATRAK International, Inc., eClinical Solutions, Inc., Bio-Optronics, Inc., ERT, MaxisIT Inc., and OmniComm Systems, Inc.
Primary Research
VynZ Research conducts extensive primary research to understand the market dynamics, validate market data and have key opinions from the industry experts. The key profiles approached within the industry includes, CEO, CFO, CTO, President, Vice President, Product Managers, Regional Heads and Others. Also, end user surveys comprising of consumers are also conducted to understand consumer behaviour.
The eClinical Solutions Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.
eClinical Solutions Market by Region
Source: VynZ Research
Source: VynZ Research
eClinical Solutions Market